Somerville, MA, United States of America

Alexis Ramos

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Dana-Farber-Cancer Institute Inc., The Board Institute, Inc., The Broad Institute, Inc.. Active years: 2016-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alexis Ramos. Retrieved from https://idiyas.com/inventor/alexis-ramos

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2016-2019

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Inventor Alexis Ramos

Introduction

Alexis Ramos is a notable inventor based in Somerville, MA (US). He has made significant contributions to the field of cancer research, particularly in the treatment of squamous cell lung cancer. With a total of 2 patents, his work has the potential to impact many lives.

Latest Patents

Ramos's latest patents focus on DDR2 mutations in squamous cell lung cancer. These patents detail methods for treating patients by detecting the presence of mutations in the discoidin domain receptor 2 (DDR2) gene. This innovative approach aims to improve patient outcomes through targeted therapies.

Career Highlights

Throughout his career, Alexis Ramos has worked with prestigious organizations such as Dana-Farber Cancer Institute Inc. and The Broad Institute, Inc. His experience in these institutions has allowed him to collaborate with leading experts in the field of oncology.

Collaborations

Some of his notable coworkers include Matthew Meyerson and Peter Hammerman. Their collective expertise has contributed to advancements in cancer research and treatment methodologies.

Conclusion

Alexis Ramos is a dedicated inventor whose work in cancer research is paving the way for innovative treatment options. His contributions are vital in the ongoing fight against squamous cell lung cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…